Pregnant Quebecers to be prioritized for COVID-19 vaccination montrealgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from montrealgazette.com Daily Mail and Mail on Sunday newspapers.
Invitae to Open New Facility in North Carolina to Support Continued Growth
News provided by
Share this article
Share this article
SAN FRANCISCO, April 20, 2021 /PRNewswire/ Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced its plans to open a new laboratory and production facility in North Carolina to further expand its capacity to meet the growing demand for genetic testing services globally. As we continue to expand to support our rapid growth worldwide, we were eager to identify a location on the East Coast that would improve our ability to serve our customers, improve our operational leverage, and build a talented team with connections to a vibrant life sciences community. We have found the ideal location in North Carolina, said Ken Knight, chief operating officer of Invitae. Our mission is to make genetic information affordable and accessible for billions of people. Our new location near the Research Triangle Park will help us brin
Invitae to Announce First Quarter 2021 Financial Results on Tuesday, May 4, 2021
News provided by
Share this article
Share this article
SAN FRANCISCO, April 20, 2021 /PRNewswire/ Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarter 2021 financial results on Tuesday, May 4, 2021 and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.
To access the conference call and webcast, please register at the link below:
The live webcast of the call and slide deck, may be accessed
here or by visiting the investors section of the company s website at
Share this article
Share this article
SAN FRANCISCO, April 15, 2021 /PRNewswire/ Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced research showing one in six people with colorectal cancer harbor genetic changes that are known to substantially increase the risk for cancer, especially in patients who were younger when diagnosed. The findings are the latest from a
landmark study of genetic testing across many solid tumor cancers and were presented at the 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting. Colorectal cancer is one of the most common types of cancer. Recently we ve seen an unfortunate increase in incidence among people younger than 50 years old. Improving our understanding of who is at risk and implementing appropriate screening strategies is essential to ensuring these cancers are caught and treated earlier when outcomes are typically better, said Robert Nussbaum, M.D., chief medi
Message :
Required fields
SAN FRANCISCO, April 8, 2021 /PRNewswire/ Invitae Corporation (NYSE: NVTA), a leading medical genetics company, has joined eMERGE Network, a nationwide effort organized and funded by the National Human Genome Research Institute (NHGRI) that connects genetic data and electronic medical record (EMR) systems to advance the use of genetics in healthcare. As a new clinical affiliate, Invitae will provide genetic testing for a study of up to 25,000 patients to evaluate the impact of population screening. Our own research has shown that people can harbor a genetic change that could put them at increased risk for conditions like cancer and heart disease. The eMERGE study is part of the work conducted by the NHGRI to improve understanding of these rates in diverse populations, with an emphasis on underrepresented minorities, and identify best practices for population screening, said Robert Nussbaum, M.D., chief medical officer at Invitae. We re proud to be